Literature DB >> 24213755

Anti-infective monoclonals step in where antimicrobials fail.

Jeffrey L Fox.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24213755     DOI: 10.1038/nbt1113-952b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Anti-infective antibodies: finding the path forward.

Authors:  Monya Baker
Journal:  Nat Biotechnol       Date:  2006-12-06       Impact factor: 54.908

2.  Anthrax drug first antibacterial mAb to win approval.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908

3.  Antimicrobial peptides stage a comeback.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2013-05       Impact factor: 54.908

  3 in total
  2 in total

1.  In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens.

Authors:  F S Rossmann; A Kropec; D Laverde; F R Saaverda; D Wobser; J Huebner
Journal:  Infection       Date:  2014-11-27       Impact factor: 3.553

Review 2.  Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease.

Authors:  Davide Corti; Jeffrey D Kearns
Journal:  Curr Opin Immunol       Date:  2016-03-23       Impact factor: 7.486

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.